Back

Mathematical modeling suggests cytotoxic T lymphocytes control growth of B16 tumor cells in collagin-fibrin gels by cytolytic and non-lytic mechanisms

Majumder, B.; Budhu, S.; Ganusov, V. V.

2023-03-29 immunology
10.1101/2023.03.28.534600 bioRxiv
Show abstract

Cytotoxic T lymphocytes (CTLs) are important in controlling some viral infections, and therapies involving transfer of large numbers of cancer-specific CTLs have been successfully used to treat several types of cancers in humans. While molecular mechanisms of how CTLs kill their targets are relatively well understood we still lack solid quantitative understanding of the kinetics and efficiency at which CTLs kill their targets in different conditions. Collagen-fibrin gel-based assays provide a tissue-like environment for the migration of CTLs, making them an attractive system to study the cytotoxicity in vitro. Budhu et al. [1] systematically varied the number of peptide (SIINFEKL)- pulsed B16 melanoma cells and SIINFEKL-specific CTLs (OT-1) and measured remaining targets at different times after target and CTL co-inoculation into collagen-fibrin gels. The authors proposed that their data were consistent with a simple model in which tumors grow exponentially and are killed by CTLs at a per capita rate proportional to the CTL density in the gel. By fitting several alternative mathematical models to these data we found that this simple "exponential-growth-mass-action-killing" model does not precisely fit the data. However, determining the best fit model proved difficult because the best performing model was dependent on the specific dataset chosen for the analysis. When considering all data that include biologically realistic CTL concentrations (E [≤] 107 cell/ml) the model in which tumors grow exponentially and CTLs suppress tumors growth non-lytically and kill tumors according to the mass-action law (SiGMA model) fitted the data with best quality. Results of power analysis suggested that longer experiments ([~] 3 - 4 days) with 4 measurements of B16 tumor cell concentrations for a range of CTL concentrations would best allow to discriminate between alternative models. Taken together, our results suggest that interactions between tumors and CTLs in collagen-fibrin gels are more complex than a simple exponential-growth- mass-action killing model and provide support for the hypothesis that CTLs impact on tumors may go beyond direct cytotoxicity.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Physical Biology
43 papers in training set
Top 0.1%
14.7%
2
PLOS ONE
4510 papers in training set
Top 15%
12.8%
3
PLOS Computational Biology
1633 papers in training set
Top 5%
6.5%
4
Cellular and Molecular Bioengineering
21 papers in training set
Top 0.1%
5.0%
5
Scientific Reports
3102 papers in training set
Top 22%
5.0%
6
Frontiers in Immunology
586 papers in training set
Top 2%
4.1%
7
Integrative Biology
13 papers in training set
Top 0.1%
3.7%
50% of probability mass above
8
Vaccines
196 papers in training set
Top 0.7%
3.1%
9
Bulletin of Mathematical Biology
84 papers in training set
Top 0.7%
2.7%
10
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.1%
11
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 1%
1.9%
12
F1000Research
79 papers in training set
Top 1%
1.9%
13
Biophysical Journal
545 papers in training set
Top 3%
1.8%
14
iScience
1063 papers in training set
Top 17%
1.5%
15
Viruses
318 papers in training set
Top 3%
1.4%
16
Biochemical and Biophysical Research Communications
78 papers in training set
Top 0.8%
1.4%
17
Mathematical Biosciences
42 papers in training set
Top 0.8%
1.3%
18
Cells
232 papers in training set
Top 5%
0.9%
19
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
20
Heliyon
146 papers in training set
Top 5%
0.8%
21
Journal of Theoretical Biology
144 papers in training set
Top 2%
0.8%
22
eLife
5422 papers in training set
Top 55%
0.8%
23
Oncotarget
15 papers in training set
Top 0.4%
0.8%
24
Molecular Immunology
14 papers in training set
Top 0.4%
0.8%
25
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
26
Frontiers in Physiology
93 papers in training set
Top 6%
0.8%
27
Mathematical Biosciences and Engineering
23 papers in training set
Top 0.6%
0.8%
28
BMC Cancer
52 papers in training set
Top 2%
0.8%
29
Bioengineering
24 papers in training set
Top 1%
0.8%
30
Journal of Biosciences
12 papers in training set
Top 0.1%
0.8%